Age-related loss in bone mineral density of rats fed lifelong on a fish oil-based diet is avoided by coenzyme Q10 addition

Nutrients

Volumn 9, Issue 2, 2017, Pages

  Varela López, Alfonso ^a   Ochoa, Julio J ^a   Llamas Elvira, José M ^b   López Frías, Magdalena ^a   Planells, Elena ^a   Ramirez Tortosa, McArmen ^a   Ramirez Tortosa, Cesar L ^c   Giampieri, Francesca ^d   Battino, Maurizio ^d   Quiles, José L ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^c Complejo Hospitalario de Jaén ^*  (Spain)

^d UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Antioxidants; Dietary fat; N 3 PUFA; Oxidative stress; Ubiquinone

Indexed keywords

CORTICOTROPIN; FISH OIL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOPROSTANE DERIVATIVE; LIPID; MONOUNSATURATED FATTY ACID; OMEGA 3 FATTY ACID; OSTEOCALCIN; OSTEOPONTIN; PARATHYROID HORMONE; PHYCOERYTHRIN; UBIDECARENONE; UBIQUINONE;

ANIMAL EXPERIMENT; ARTICLE; BONE DENSITY; BONE DISEASE; BONE METABOLISM; CELL DIFFERENTIATION; CONTROLLED STUDY; DIET; DIET SUPPLEMENTATION; DNA STRAND BREAKAGE; ELECTROCHEMICAL DETECTION; FOOD INTAKE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; OSTEOCLAST ACTIVITY; OXIDATIVE STRESS; RAT; SPILLAGE; ANALOGS AND DERIVATIVES; ANIMAL; DIETARY SUPPLEMENT; DNA DAMAGE; DRUG EFFECTS; FEMUR; LIPID PEROXIDATION; OSTEOPOROSIS; WISTAR RAT;

ANIMALS; BONE DENSITY; DIET; DIETARY SUPPLEMENTS; DNA DAMAGE; FATTY ACIDS, OMEGA-3; FEMUR; FISH OILS; LIPID PEROXIDATION; MALE; OSTEOPOROSIS; OXIDATIVE STRESS; RATS; RATS, WISTAR; UBIQUINONE;

EID: 85013748930     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu9020176     Document Type: Article

References (118)

1. Alvioli, L.V.; Lindsay, R. The female osteoporotic syndrome(s). In Metabolic Bone Disease and Clinically Related Disorder; Alvioli, L.V., Krane, S.M., Eds.; WB Saunders Company: Philadelphia, PA, USA, 1990; pp. 397–451.
2. Sowers, M. Clinical epidemiology and osteoporosis. Measures and their interpretation. Endocrinol. Metab. Clin. N. Am. 1997, 26, 219–231. [CrossRef]
3. Szulc, P.; Seeman, E.; Duboeuf, F.; Sornay-Rendu, E.; Delmas, P.D. Bone fragility: Failure of periosteal apposition to compensate for increased endocortical resorption in postmenopausal women. J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res. 2006, 21, 1856–1863. [CrossRef] [PubMed]
4. Lauretani, F.; Bandinelli, S.; Griswold, M.E.; Maggio, M.; Semba, R.; Guralnik, J.M.; Ferrucci, L. Longitudinal changes in BMD and bone geometry in a population-based study. J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res. 2008, 23, 400–408. [CrossRef] [PubMed]
5. Edwards, M.H.; Dennison, E.M.; Aihie Sayer, A.; Fielding, R.; Cooper, C. Osteoporosis and sarcopenia in older age. Bone 2015, 80, 126–130. [CrossRef] [PubMed]
6. National Institute of Health. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy Osteoporosis prevention, diagnosis, and therapy. JAMA 2001, 285, 785–795.
7. Bliuc, D.; Nguyen, N.D.; Milch, V.E.; Nguyen, T.V.; Eisman, J.A.; Center, J.R. Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA 2009, 301, 513–521. [CrossRef] [PubMed]
8. Willson, T.; Nelson, S.D.; Newbold, J.; Nelson, R.E.; LaFleur, J. The clinical epidemiology of male osteoporosis: A review of the recent literature. Clin. Epidemiol. 2015, 7, 65–76. [PubMed]
9. Penrod, J.D.; Litke, A.; Hawkes, W.G.; Magaziner, J.; Doucette, J.T.; Koval, K.J.; Silberzweig, S.B.; Egol, K.A.; Siu, A.L. The association of race, gender, and comorbidity with mortality and function after hip fracture. J. Gerontol. A. Biol. Sci. Med. Sci. 2008, 63, 867–872. [CrossRef] [PubMed]
10. Endo, Y.; Aharonoff, G.B.; Zuckerman, J.D.; Egol, K.A.; Koval, K.J. Gender differences in patients with hip fracture: A greater risk of morbidity and mortality in men. J. Orthop. Trauma 2005, 19, 29–35. [CrossRef] [PubMed]
11. Chin, K.-Y.; Ima-Nirwana, S. Olives and Bone: A Green Osteoporosis Prevention Option. Int. J. Environ. Res. Public. Health. 2016, 13, 755. [CrossRef] [PubMed]
12. Sacco, S.M.; Horcajada, M.-N.; Offord, E. Phytonutrients for bone health during ageing. Br. J. Clin. Pharmacol. 2013, 75, 697–707. [CrossRef] [PubMed]
13. Bonjour, J.-P. Protein intake and bone health. Int. J. Vitam. Nutr. Res. 2011, 81, 134–142. [CrossRef] [PubMed]
14. Heaney, R.P. Calcium, dairy products and osteoporosis. J. Am. Coll. Nutr. 2000, 19, 83S–99S. [CrossRef] [PubMed]
15. Heaney, R.P. Skeletal development and maintenance: The role of calcium and vitamin D. Adv. Endocrinol. Metab. 1995, 6, 17–38. [PubMed]
16. Corwin, R.L.; Hartman, T.J.; Maczuga, S.A.; Graubard, B.I. Dietary saturated fat intake is inversely associated with bone density in humans: Analysis of NHANES III. J. Nutr. 2006, 136, 159–165. [PubMed]
17. Kato, I.; Toniolo, P.; Zeleniuch-Jacquotte, A.; Shore, R.E.; Koenig, K.L.; Akhmedkhanov, A.; Riboli, E. Diet, smoking and anthropometric indices and postmenopausal bone fractures: A prospective study. Int. J. Epidemiol. 2000, 29, 85–92. [CrossRef] [PubMed]
18. Järvinen, R.; Tuppurainen, M.; Erkkilä, A.T.; Penttinen, P.; Kärkkäinen, M.; Salovaara, K.; Jurvelin, J.S.; Kröger, H. Associations of dietary polyunsaturated fatty acids with bone mineral density in elderly women. Eur. J. Clin. Nutr. 2012, 66, 496–503. [CrossRef] [PubMed]
19. Kruger, M.C.; Claassen, N.; Smuts, C.M.; Potgieter, H.C. Correlation between essential fatty acids and parameters of bone formation and degradation. Asia Pac. J. Clin. Nutr. 1997, 6, 235–238. [PubMed]
20. Kruger, M.C.; Schollum, L.M. Is docosahexaenoic acid more effective than eicosapentaenoic acid for increasing calcium bioavailability? Prostaglandins Leukot. Essent. Fatty Acids 2005, 73, 327–334. [CrossRef] [PubMed]
21. Macdonald, H.M.; New, S.A.; Golden, M.H.N.; Campbell, M.K.; Reid, D.M. Nutritional associations with bone loss during the menopausal transition: Evidence of a beneficial effect of calcium, alcohol, and fruit and vegetable nutrients and of a detrimental effect of fatty acids. Am. J. Clin. Nutr. 2004, 79, 155–165. [PubMed]
22. Harris, M.; Farrell, V.; Houtkooper, L.; Going, S.; Lohman, T. Associations of polyunsaturated fatty acid intake with bone mineral density in postmenopausal women. J. Osteoporos. 2015, 2015, 737521. [CrossRef] [PubMed]
23. Muraki, S.; Yamamoto, S.; Ishibashi, H.; Oka, H.; Yoshimura, N.; Kawaguchi, H.; Nakamura, K. Diet and lifestyle associated with increased bone mineral density: Cross-sectional study of Japanese elderly women at an osteoporosis outpatient clinic. J. Orthop. Sci. Off. J. Jpn. Orthop. Assoc. 2007, 12, 317–320. [CrossRef] [PubMed]
24. Poulsen, R.C.; Kruger, M.C. Detrimental effect of eicosapentaenoic acid supplementation on bone following ovariectomy in rats. Prostaglandins Leukot. Essent. Fatty Acids 2006, 75, 419–427. [CrossRef] [PubMed]
25. Virtanen, J.K.; Mozaffarian, D.; Cauley, J.A.; Mukamal, K.J.; Robbins, J.; Siscovick, D.S. Fish consumption, bone mineral density, and risk of hip fracture among older adults: The cardiovascular health study. J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res. 2010, 25, 1972–1979. [CrossRef] [PubMed]
26. Mangano, K.M.; Kerstetter, J.E.; Kenny, A.M.; Insogna, K.L.; Walsh, S.J. An investigation of the association between omega 3 FA and bone mineral density among older adults: Results from the National Health and Nutrition Examination Survey years 2005–2008. Osteoporos. Int. J. Establ. Result Coop. Eur. Found. Osteoporos. Natl. Osteoporos. Found. USA 2014, 25, 1033–1041. [CrossRef] [PubMed]
27. Weiss, L.A.; Barrett-Connor, E.; von Mühlen, D. Ratio of n-6 to n-3 fatty acids and bone mineral density in older adults: The Rancho Bernardo Study. Am. J. Clin. Nutr. 2005, 81, 934–938. [PubMed]
28. 2 Study. Am. J. Clin. Nutr. 2007, 85, 803–807. [PubMed]
29. Sun, D.; Krishnan, A.; Zaman, K.; Lawrence, R.; Bhattacharya, A.; Fernandes, G. Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice. J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res. 2003, 18, 1206–1216. [CrossRef] [PubMed]
30. Sun, L.; Tamaki, H.; Ishimaru, T.; Teruya, T.; Ohta, Y.; Katsuyama, N.; Chinen, I. Inhibition of osteoporosis due to restricted food intake by the fish oils DHA and EPA and perilla oil in the rat. Biosci. Biotechnol. Biochem. 2004, 68, 2613–2615. [CrossRef] [PubMed]
31. Claassen, N.; Potgieter, H.C.; Seppa, M.; Vermaak, W.J.; Coetzer, H.; Van Papendorp, D.H.; Kruger, M.C. Supplemented gamma-linolenic acid and eicosapentaenoic acid influence bone status in young male rats: Effects on free urinary collagen crosslinks, total urinary hydroxyproline, and bone calcium content. Bone 1995, 16, 385S–392S. [CrossRef]
32. Mollard, R.C.; Kovacs, H.R.; Fitzpatrick-Wong, S.C.; Weiler, H.A. Low levels of dietary arachidonic and docosahexaenoic acids improve bone mass in neonatal piglets, but higher levels provide no benefit. J. Nutr. 2005, 135, 505–512. [PubMed]
33. Green, K.H.; Wong, S.C.F.; Weiler, H.A. The effect of dietary n-3 long-chain polyunsaturated fatty acids on femur mineral density and biomarkers of bone metabolism in healthy, diabetic and dietary-restricted growing rats. Prostaglandins Leukot. Essent. Fatty Acids 2004, 71, 121–130. [CrossRef] [PubMed]
34. Liu, D.; Veit, H.P.; Denbow, D.M. Effects of long-term dietary lipids on mature bone mineral content, collagen, crosslinks, and prostaglandin E2 production in Japanese quail. Poult. Sci. 2004, 83, 1876–1883. [CrossRef] [PubMed]
35. Musacchio, E.; Priante, G.; Budakovic, A.; Baggio, B. Effects of unsaturated free fatty acids on adhesion and on gene expression of extracellular matrix macromolecules in human osteoblast-like cell cultures. Connect. Tissue Res. 2007, 48, 34–38. [CrossRef] [PubMed]
36. Watkins, B.A.; Li, Y.; Seifert, M.F. Dietary ratio of n-6/n-3 PUFAs and docosahexaenoic acid: Actions on bone mineral and serum biomarkers in ovariectomized rats. J. Nutr. Biochem. 2006, 17, 282–289. [CrossRef] [PubMed]
37. Watkins, B.A.; Lippman, H.E.; Le Bouteiller, L.; Li, Y.; Seifert, M.F. Bioactive fatty acids: Role in bone biology and bone cell function. Prog. Lipid Res. 2001, 40, 125–148. [CrossRef]
38. González-Alonso, A.; Ramírez-Tortosa, C.L.; Varela-López, A.; Roche, E.; Arribas, M.I.; Ramírez-Tortosa, M.C.; Giampieri, F.; Ochoa, J.J.; Quiles, J.L. Sunflower Oil but Not Fish Oil Resembles Positive Effects of Virgin Olive Oil on Aged Pancreas after Life-Long Coenzyme Q Addition. Int. J. Mol. Sci. 2015, 16, 23425–23445. [CrossRef] [PubMed]
39. Coetzee, M.; Haag, M.; Joubert, A.M.; Kruger, M.C. Effects of arachidonic acid, docosahexaenoic acid and prostaglandin E(2) on cell proliferation and morphology of MG-63 and MC3T3-E1 osteoblast-like cells. Prostaglandins Leukot. Essent. Fatty Acids 2007, 76, 35–45. [CrossRef] [PubMed]
40. Maurin, A.C.; Chavassieux, P.M.; Vericel, E.; Meunier, P.J. Role of polyunsaturated fatty acids in the inhibitory effect of human adipocytes on osteoblastic proliferation. Bone 2002, 31, 260–266. [CrossRef]
41. Almeida, M.; Han, L.; Martin-Millan, M.; Plotkin, L.I.; Stewart, S.A.; Roberson, P.K.; Kousteni, S.; O’Brien, C.A.; Bellido, T.; Parfitt, A.M.; et al. Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids. J. Biol. Chem. 2007, 282, 27285–27297. [CrossRef] [PubMed]
42. Callaway, D.A.; Jiang, J.X. Reactive oxygen species and oxidative stress in osteoclastogenesis, skeletal aging and bone diseases. J. Bone Miner. Metab. 2015, 33, 359–370. [CrossRef] [PubMed]
43. Manolagas, S.C. From estrogen-centric to aging and oxidative stress: A revised perspective of the pathogenesis of osteoporosis. Endocr. Rev. 2010, 31, 266–300. [CrossRef] [PubMed]
44. 10 protects from aging-related oxidative stress and improves mitochondrial function in heart of rats fed a polyunsaturated fatty acid (PUFA)-rich diet. J. Gerontol. Biol. Sci. Med. Sci. 2005, 60, 970–975. [CrossRef]
45. Pasco, J.A.; Henry, M.J.; Wilkinson, L.K.; Nicholson, G.C.; Schneider, H.G.; Kotowicz, M.A. Antioxidant vitamin supplements and markers of bone turnover in a community sample of nonsmoking women. J. Womens Health 2006, 15, 295–300. [CrossRef] [PubMed]
46. Sanders, K.M.; Kotowicz, M.A.; Nicholson, G.C. Potential role of the antioxidant N-acetylcysteine in slowing bone resorption in early post-menopausal women: A pilot study. Transl. Res. J. Lab. Clin. Med. 2007, 150, 215. [CrossRef] [PubMed]
47. Ayaz, M.; Tuncer, S.; Okudan, N.; Gokbel, H. Coenzyme Q(10) and alpha-lipoic acid supplementation in diabetic rats: Conduction velocity distributions. Methods Find. Exp. Clin. Pharmacol. 2008, 30, 367–374. [CrossRef] [PubMed]
48. Shetty, K. The role of salivary cytokines in the etiology and progression of periodontal disease. Gen. Dent. 2006, 54, 140–143. [PubMed]
49. 10 supplementation decelerates senescence in SAMP1 mice. Exp. Gerontol. 2006, 41, 130–140. [CrossRef] [PubMed]
50. López-Lluch, G.; Rodríguez-Aguilera, J.C.; Santos-Ocaña, C.; Navas, P. Is coenzyme Q a key factor in aging? Mech. Ageing Dev. 2010, 131, 225–235. [CrossRef] [PubMed]
51. Ernster, L.; Dallner, G. Biochemical, physiological and medical aspects of Ubiquinone function. Biochim. Biophys. Acta 1995, 1271, 195–204. [CrossRef]
52. Frei, B.; Kim, M.C.; Ames, B.N. Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations. Proc. Natl. Acad. Sci. USA 1990, 87, 4879–4883. [CrossRef] [PubMed]
53. Bentinger, M.; Tekle, M.; Dallner, G. Coenzyme Q–biosynthesis and functions. Biochem. Biophys. Res. Commun. 2010, 396, 74–79. [CrossRef] [PubMed]
54. 1 complex in the respiratory chain: Protonmotive ubiquinone cycle. FEBS Lett. 1975, 56, 1–6. [CrossRef]
55. Varela-López, A.; Giampieri, F.; Battino, M.; Quiles, J.L. Coenzyme Q and Its Role in the Dietary Therapy against Aging. Molecules 2016, 21, 373. [CrossRef] [PubMed]
56. Genova, M.L.; Lenaz, G. New developments on the functions of coenzyme Q in mitochondria. Biofactors 2011, 37, 330–354. [CrossRef] [PubMed]
57. Quiles, J.L.; Ochoa, J.J.; Huertas, J.R.; Mataix, J. Coenzyme Q supplementation protects from age-related DNA double-strand breaks and increases lifespan in rats fed on a PUFA-rich diet. Exp. Gerontol. 2004, 39, 189–194. [CrossRef] [PubMed]
58. 10 supplementation on age-related oxidative stress and mitochondrial function in liver and skeletal muscle of rats fed on a polyunsaturated fatty acid (PUFA)-rich diet. J. Gerontol. Biol. Sci. Med. Sci. 2007, 62, 1211–1218. [CrossRef]
59. Quiles, J.L.; Pamplona, R.; Ramirez-Tortosa, M.C.; Naudí, A.; Portero-Otin, M.; Araujo-Nepomuceno, E.; López-Frías, M.; Battino, M.; Ochoa, J.J. Coenzyme Q addition to an n-6 PUFA-rich diet resembles benefits on age-related mitochondrial DNA deletion and oxidative stress of a MUFA-rich diet in rat heart. Mech. Ageing Dev. 2010, 131, 38–47. [CrossRef] [PubMed]
60. 10. Free Radic. Biol. Med. 2011, 50, 1053–1064. [CrossRef] [PubMed]
61. Varela-Lopez, A.; Bullon, P.; Battino, M.; Ramirez-Tortosa, M.C.; Ochoa, J.J.; Cordero, M.D.; Ramirez-Tortosa, C.L.; Rubini, C.; Zizzi, A.; Quiles, J.L. Coenzyme Q protects against age-related alveolar bone loss associated to n-6 PUFA rich-diets by modulating mitochondrial mechanisms. J. Gerontol. A Biol. Sci. Med. Sci. 2015, 71, 593–600. [CrossRef] [PubMed]
62. Reeves, P.G. Components of the AIN-93 diets as improvements in the AIN-76A diet. J. Nutr. 1997, 127, 838S–841S. [PubMed]
63. Sengupta, P. The Laboratory Rat: Relating Its Age with Human’s. Int. J. Prev. Med. 2013, 4, 624–630. [PubMed]
64. Lepage, G.; Roy, C.C. Direct transesterification of all classes of lipids in a one-step reaction. J. Lipid Res. 1986, 27, 114–120. [PubMed]
65. Quiles, J.L.; Huertas, J.R.; Mañas, M.; Ochoa, J.J.; Battino, M.; Mataix, J. Oxidative stress induced by exercise and dietary fat modulates the coenzyme Q and vitamin A balance between plasma and mitochondria. Int. J. Vitam. Nutr. Res. 1999, 69, 243–249. [CrossRef] [PubMed]
66. MacCrehan, W.A. Determination of retinol, alpha-tocopherol, and beta-carotene in serum by liquid chromatography. Methods Enzymol. 1990, 189, 172–181. [PubMed]
67. Quiles, J.L.; Ochoa, J.J.; Ramirez-Tortosa, M.C.; Linde, J.; Bompadre, S.; Battino, M.; Narbona, E.; Maldonado, J.; Mataix, J. Coenzyme Q concentration and total antioxidant capacity of human milk at different stages of lactation in mothers of preterm and full-term infants. Free Radic. Res. 2006, 40, 199–206. [CrossRef] [PubMed]
68. Collins, A.R.; Dusinská, M.; Gedik, C.M.; Stĕtina, R. Oxidative damage to DNA: Do we have a reliable biomarker? Environ. Health Perspect. 1996, 104, 465–469. [CrossRef] [PubMed]
69. Quiles, J.L.; Ochoa, J.J.; Ramirez-Tortosa, C.; Battino, M.; Huertas, J.R.; Martín, Y.; Mataix, J. Dietary fat type (virgin olive vs. sunflower oils) affects age-related changes in DNA double-strand-breaks, antioxidant capacity and blood lipids in rats. Exp. Gerontol. 2004, 39, 1189–1198. [CrossRef] [PubMed]
70. Quiles, J.L.; Martínez, E.; Ibáñez, S.; Ochoa, J.J.; Martín, Y.; López-Frías, M.; Huertas, J.R.; Mataix, J. Ageing-related tissue-specific alterations in mitochondrial composition and function are modulated by dietary fat type in the rat. J. Bioenerg. Biomembr. 2002, 34, 517–524. [CrossRef] [PubMed]
71. Quiles, J.L.; Huertas, J.R.; Mañas, M.; Battino, M.; Mataix, J. Physical exercise affects the lipid profile of mitochondrial membranes in rats fed with virgin olive oil or sunflower oil. Br. J. Nutr. 1999, 81, 21–24. [PubMed]
72. Kanis, J.A.; Burlet, N.; Cooper, C.; Delmas, P.D.; Reginster, J.-Y.; Borgstrom, F.; Rizzoli, R.; and on behalf of the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF). European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos. Int. 2008, 19, 399–428. [CrossRef] [PubMed]
73. World Health Organization (WHO). Assessment of osteoporosis at the primary health care level. Summary Report of a WHO Scientific Group 2007; WHO: Geneva, Switzerland.
74. Kanis, J.A.; on behalf of the World Health Organization Scientific Group. Assessment of Osteoporosis at the Primary Health-Care Level; WHO Collaborating Centre, University of Sheffield: Sheffield, UK, 2007.
75. Marshall, D.; Johnell, O.; Wedel, H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. Br. Med. J. 1996, 312, 1254–1259. [CrossRef]
76. Kanis, J.A. Diagnosis of osteoporosis and assessment of fracture risk. Lancet 2002, 359, 1929–1936. [CrossRef]
77. 10 in mitigating spinal cord injury-induced osteoporosis. Mol. Med. Rep. 2015, 12, 3909–3915. [CrossRef] [PubMed]
78. Nair, A.B.; Jacob, S. A simple practice guide for dose conversion between animals and human. J. Basic Clin. Pharm. 2016, 7, 27–31. [CrossRef] [PubMed]
79. 10 from over the counter supplements. Nutr. Res. 2002, 22, 919–929. [CrossRef]
80. Hosoe, K.; Kitano, M.; Kishida, H.; Kubo, H.; Fuji, K.; Kitahara, M. Study on safety and bioavailability of ubiquinol (Kaneka QH TM) after single and 4-week multiple oral administration to healthy volunteers. Regul. Toxicol. Pharmacol. 2007, 47, 19–28. [CrossRef] [PubMed]
81. 10 formulations. J. Funct. Food 2009, 1, 65–73. [CrossRef]
82. Van Papendorp, D.H.; Coetzer, H.; Kruger, M.C. Biochemical profile of osteoporotic patients on essential fatty acid supplementation. Nutr. Res. 1995, 15, 325–334. [CrossRef]
83. Shen, C.-L.; Yeh, J.K.; Rasty, J.; Li, Y.; Watkins, B.A. Protective effect of dietary long-chain n-3 polyunsaturated fatty acids on bone loss in gonad-intact middle-aged male rats. Br. J. Nutr. 2006, 95, 462–468. [CrossRef] [PubMed]
84. Subraman, V.; Thiyagarajan, M.; Malathi, N.; Rajan, S.T. OPN–Revisited. J. Clin. Diagn. Res. JCDR 2015, 9, ZE10–ZE13. [CrossRef] [PubMed]
85. Wang, K.X.; Shi, Y.F.; Ron, Y.; Kazanecki, C.C.; Denhardt, D.T. Plasma osteopontin modulates chronic restraint stress-induced thymus atrophy by regulating stress hormones: Inhibition by an anti-osteopontin monoclonal antibody. J. Immunol. 2009, 182, 2485–2491. [CrossRef] [PubMed]
86. Scatena, M.; Liaw, L.; Giachelli, C.M. Osteopontin. Arterioscler. Thromb. Vasc. Biol. 2007, 27, 2302–2309. [CrossRef] [PubMed]
87. Standal, T.; Borset, M.; Sundan, A. Role of osteopontin in adhesion, migration, cell survival and bone remodeling. Exp. Oncol. 2004, 26, 179–184. [PubMed]
88. Anborgh, P.H.; Mutrie, J.C.; Tuck, A.B.; Chambers, A.F. Pre- and post-translational regulation of osteopontin in cancer. J. Cell Commun. Signal. 2011, 5, 111–122. [CrossRef] [PubMed]
89. Das, U.N. Essential fatty acids and osteoporosis. Nutrition 2000, 16, 386–390. [CrossRef]
90. Altindag, O.; Erel, O.; Soran, N.; Celik, H.; Selek, S. Total oxidative/anti-oxidative status and relation to bone mineral density in osteoporosis. Rheumatol. Int. 2008, 28, 317–321. [CrossRef] [PubMed]
91. Basu, S.; Michaëlsson, K.; Olofsson, H.; Johansson, S.; Melhus, H. Association between oxidative stress and bone mineral density. Biochem. Biophys. Res. Commun. 2001, 288, 275–279. [CrossRef] [PubMed]
92. Cervellati, C.; Bonaccorsi, G.; Cremonini, E.; Bergamini, C.M.; Patella, A.; Castaldini, C.; Ferrazzini, S.; Capatti, A.; Picarelli, V.; Pansini, F.S.; et al. Bone mass density selectively correlates with serum markers of oxidative damage in post-menopausal women. Clin. Chem. Lab. Med. 2013, 51, 333–338. [CrossRef] [PubMed]
93. Maggio, D.; Barabani, M.; Pierandrei, M.; Polidori, M.C.; Catani, M.; Mecocci, P.; Senin, U.; Pacifici, R.; Cherubini, A. Marked decrease in plasma antioxidants in aged osteoporotic women: Results of a cross-sectional study. J. Clin. Endocrinol. Metab. 2003, 88, 1523–1527. [CrossRef] [PubMed]
94. Sharma, T.; Islam, N.; Ahmad, J.; Akhtar, N.; Beg, M. Correlation between bone mineral density and oxidative stress in postmenopausal women. Indian J. Endocrinol. Metab. 2015, 19, 491–497. [PubMed]
95. 10 Modifies the Expression of Proinflammatory and Endoplasmic Reticulum Stress–Related Genes in Elderly Men and Women. J. Gerontol. Biol. Sci. Med. Sci. 2012, 67A, 3–10. [CrossRef] [PubMed]
96. 10 induces postprandial changes in p53 in response to oxidative DNA damage in elderly subjects. Age Drodr. 2011, 34, 389–403. [CrossRef] [PubMed]
97. Isales, C.M.; Zaidi, M.; Blair, H.C. ACTH is a novel regulator of bone mass. Ann. N. Y. Acad. Sci. 2010, 1192, 110–116. [CrossRef] [PubMed]
98. Jilka, R.L.; Weinstein, R.S.; Bellido, T.; Roberson, P.; Parfitt, A.M.; Manolagas, S.C. Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J. Clin. Investig. 1999, 104, 439–446. [CrossRef] [PubMed]
99. Chen, A.B.; Minami, K.; Raposo, J.F.; Matsuura, N.; Koizumi, M.; Yokota, H.; Ferreira, H.G. Transient modulation of calcium and parathyroid hormone stimulates bone formation. Endocrine 2016, 54, 232–240. [CrossRef] [PubMed]
100. Mancini, T.; Doga, M.; Mazziotti, G.; Giustina, A. Cushing’s syndrome and bone. Pituitary 2004, 7, 249–252. [CrossRef] [PubMed]
101. Silverman, S.L.; Lane, N.E. Glucocorticoid-induced osteoporosis. Curr. Osteoporos. Rep. 2009, 7, 23–26. [CrossRef] [PubMed]
102. Boden, S.D.; Hair, G.; Titus, L.; Racine, M.; McCuaig, K.; Wozney, J.M.; Nanes, M.S. Glucocorticoid-induced differentiation of fetal rat calvarial osteoblasts is mediated by bone morphogenetic protein-6. Endocrinology 1997, 138, 2820–2828. [CrossRef] [PubMed]
103. Zhong, Q.; Sridhar, S.; Ruan, L.; Ding, K.-H.; Xie, D.; Insogna, K.; Kang, B.; Xu, J.; Bollag, R.J.; Isales, C.M. Multiple melanocortin receptors are expressed in bone cells. Bone 2005, 36, 820–831. [CrossRef] [PubMed]
104. Mancini, A.; Leone, E.; Silvestrini, A.; Festa, R.; Di Donna, V.; De Marinis, L.; Pontecorvi, A.; Littarru, G.P.; Meucci, E. Evaluation of antioxidant systems in pituitary-adrenal axis diseases. Pituitary 2010, 13, 138–145. [CrossRef] [PubMed]
105. 10 evaluation in pituitary-adrenal axis disease: Preliminary data. BioFactors Oxf. Engl. 2005, 25, 197–199. [CrossRef]
106. Nakagawa, N.; Kinosaki, M.; Yamaguchi, K.; Shima, N.; Yasuda, H.; Yano, K.; Morinaga, T.; Higashio, K. RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis. Biochem. Biophys. Res. Commun. 1998, 253, 395–400. [CrossRef] [PubMed]
107. Yasuda, H.; Shima, N.; Nakagawa, N.; Yamaguchi, K.; Kinosaki, M.; Goto, M.; Mochizuki, S.I.; Tsuda, E.; Morinaga, T.; Udagawa, N.; et al. A novel molecular mechanism modulating osteoclast differentiation and function. Bone 1999, 25, 109–113. [CrossRef]
108. Raggatt, L.J.; Partridge, N.C. Cellular and molecular mechanisms of bone remodeling. J. Biol. Chem. 2010, 285, 25103–25108. [CrossRef] [PubMed]
109. Kerschan-Schindl, K.; Wendlova, J.; Kudlacek, S.; Gleiss, A.; Woloszczuk, W.; Pietschmann, P. Serum levels of receptor activator of nuclear factor kappaB ligand (RANKL) in healthy women and men. Exp. Clin. Endocrinol. Diabetes Off. J. Ger. Soc. Endocrinol. Ger. Diabetes Assoc. 2008, 116, 491–495. [CrossRef] [PubMed]
110. Liu, J.M.; Zhao, H.Y.; Ning, G.; Zhao, Y.J.; Chen, Y.; Zhang, Z.; Sun, L.H.; Xu, M.-Y.; Chen, J.L. Relationships between the changes of serum levels of OPG and RANKL with age, menopause, bone biochemical markers and bone mineral density in Chinese women aged 20–75. Calcif. Tissue Int. 2005, 76, 1–6. [CrossRef] [PubMed]
111. Bullon, P.; Battino, M.; Varela-Lopez, A.; Perez-Lopez, P.; Granados-Principal, S.; Ramirez-Tortosa, M.C.; Ochoa, J.J.; Cordero, M.D.; Gonzalez-Alonso, A.; Ramirez-Tortosa, C.L.; et al. Diets based on virgin olive oil or fish oil but not on sunflower oil prevent age-related alveolar bone resorption by mitochondrial-related mechanisms. PLoS ONE 2013, 8, e74234. [CrossRef] [PubMed]
112. 10, selenite, and curcumin, inhibited osteoclast differentiation by suppressing reactive oxygen species generation. Biochem. Biophys. Res. Commun. 2012, 418, 247–253. [CrossRef] [PubMed]
113. 10 regulates osteoclast and osteoblast differentiation. J. Food Sci. 2013, 78, H785–H891. [CrossRef] [PubMed]
114. 10 protect heart mitochondria from peroxidative damage during aging. Biofactors 1999, 9, 337–343. [CrossRef] [PubMed]
115. Ochoa, J.J.; Quiles, J.L.; Ibáñez, S.; Martínez, E.; López-Frías, M.; Huertas, J.R.; Mataix, J. Aging-related oxidative stress depends on dietary lipid source in rat postmitotic tissues. J. Bioenerg. Biomembr. 2003, 35, 267–275. [CrossRef] [PubMed]
116. Roche, E.; Ramírez-Tortosa, C.L.; Arribas, M.I.; Ochoa, J.J.; Sirvent-Belando, J.E.; Battino, M.; Ramírez-Tortosa, M.C.; González-Alonso, A.; Pérez-López, M.P.; Quiles, J.L. Comparative analysis of pancreatic changes in aged rats fed life long with sunflower, fish, or olive oils. J. Gerontol. A Biol. Sci. Med. Sci. 2014, 69, 934–944. [CrossRef] [PubMed]
117. Fatokun, A.A.; Stone, T.W.; Smith, R.A. Responses of differentiated MC3T3-E1 osteoblast-like cells to reactive oxygen species. Eur. J. Pharmacol. 2008, 587, 35–41. [CrossRef] [PubMed]
118. Bethel, M.; Chitteti, B.R.; Srour, E.F.; Kacena, M.A. The changing balance between osteoblastogenesis and adipogenesis in aging and its impact on hematopoiesis. Curr. Osteoporos. Rep. 2013, 11, 99–106. [CrossRef] [PubMed]